SMC Abca1 and Abcg1 Deficiency Enhances Urinary Bladder Distension but Not Atherosclerosis.

Halmos, Benedek; La Rose, Anouk M; Methorst, Daisey; Groenen, Anouk G; Nakládal, Dalibor; Bazioti, Venetia; Koster, Mirjam H; Kloosterhuis, Niels J et al. · Circ Res · 2025

basic_science · Level V

Where this comes from

Abstract

Smooth muscle cells (SMCs) regulate blood flow distribution via vasoconstriction mediated by α-ARs (α-adrenergic receptors). Plasma membrane cholesterol accumulation affects α<sub>1</sub>-AR signaling and promotes loss of SMC contractile markers in vitro. ABCA1 and ABCG1 (ATP-binding cassette transporter A1 and G1) mediate cholesterol efflux to HDL (high-density lipoprotein). ABCA1/ABCG1 show high expression in medial and low expression in intimal SMCs of atherosclerotic plaques. The role of ABCA1 and ABCG1 in SMC-mediated vasoconstriction and atherogenesis remains poorly understood. We generated mice with SMC-specific <i>Abca1/Abcg1</i> deficiency on the low-density lipoprotein receptor-deficient (<i>Ldlr</i><sup><i>-</i></sup><sup><i>/</i></sup><sup><i>-</i></sup>) background by crossbreeding <i>Abca1</i><sup><i>fl/fl</i></sup><i>Abcg1</i><sup><i>fl/fl</i></sup><i>Ldlr</i><sup><i>-/-</i></sup> mice with <i>Myh11Cre</i><sup><i>ERT2</i></sup> transgenic mice. To induce SMC cholesterol accumulation and atherogenesis, we fed <i>Myh11Cre</i><sup><i>ERT2</i></sup><i>Abca1</i><sup><i>fl/fl</i></sup><i>Abcg1</i><sup><i>fl/fl</i></sup><i>Ldlr</i><sup><i>-/-</i></sup>, <i>Myh11Cre</i><sup><i>ERT2</i></sup><i>Abca1</i><sup><i>fl/fl</i></sup><i>Ldlr</i><sup><i>-/-</i></sup>, <i>Myh11Cre</i><sup><i>ERT2</i></sup><i>Abcg1</i><sup><i>fl/fl</i></sup><i>Ldlr</i><sup><i>-/-</i></sup>, and <i>Myh11Cre</i><sup><i>ERT2</i></sup><i>Ldlr</i><sup><i>-/-</i></sup> mice Western-type diet for 16 weeks. Combined <i>SMC-Abca1/Abcg1</i> deficiency increased vasoconstriction in aortic rings induced by the α<sub>1</sub>-AR agonist phenylephrine. Unexpectedly, <i>SMC-Abca1/Abcg1</i> deficiency induced urinary bladder distension by >20-fold. This was reversed by the α<sub>1</sub>-AR antagonist tamsulosin, indicating its dependence on bladder neck SMC constriction. Moreover, <i>SMC-Abca1/Abcg1</i> deficiency decreased contractile markers and increased macrophage and fibroblast markers in bladder SMCs, indicating SMC transdifferentiation. This was accompanied by free cholesterol accumulation and increased endoplasmic reticulum stress. <i>SMC-Abca1/Abcg1</i> deficiency did not induce thoracic aorta SMC transdifferentiation, presumably due to increased cholesteryl ester accumulation and no endoplasmic reticulum stress in thoracic aorta SMCs. Surprisingly, <i>SMC-Abca1/Abcg1</i> deficiency did not affect atherosclerotic lesion size or composition in the aortic root or brachiocephalic artery. We uncover a new role of SMC cholesterol efflux pathways in suppressing α<sub>1</sub>-AR-mediated vasoconstriction and bladder SMC transdifferentiation, decreasing urinary bladder distension. Our data may provide a mechanistic link for the association between urinary bladder distension and diabetes in humans, particularly because diabetes is associated with decreased cholesterol efflux. <i>SMC-Abca1/Abcg1</i> deficiency did not affect atherosclerotic lesion size or plaque composition, presumably due to low expression of <i>Abca1/Abcg1</i> in intimal SMCs.

Medical subject headings